Douglas Kerr
Chief Medical Officer · 6 filings · Latest: Sep 4, 2026
Dyne Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
DYN | Kerr Douglas | — | Sep 8, 2026 | Proposed Sale | $18.89 | 35 | $661 | — | |
DYN | Douglas Kerr | Chief Medical Officer | Sep 8, 2026 | Sale | $18.88 | 1,290 | $24.4K | 162,564 | |
DYN | Douglas Kerr | Chief Medical Officer | Sep 4, 2026 | Sale | $24.35 | 3,745 | $91.2K | 163,854 | |
DYN | Kerr Douglas | — | Sep 4, 2026 | Proposed Sale | $24.35 | 5,000 | $121.7K | — | |
DYN | Douglas Kerr | Chief Medical Officer | Aug 13, 2026 | Sale | $26.28 | 1,556 | $40.9K | 167,599 | |
DYN | Kerr Douglas | — | Aug 13, 2026 | Proposed Sale | $26.28 | 2,443 | $64.2K | — | |
DYN | Douglas Kerr | Chief Medical Officer | Jun 16, 2026 | Sale | $18.33 | 887 | $16.3K | 169,155 | |
DYN | Douglas Kerr | Chief Medical Officer | May 13, 2026 | Sale | $18.36 | 1,564 | $28.7K | 170,042 | |
DYN | Douglas Kerr | Chief Medical Officer | Mar 5, 2026 | Sale | $14.90 | 904 | $13.5K | 171,606 | |
DYN | Kerr Douglas | — | Dec 5, 2025 | Proposed Sale | $20.72 | 880 | $18.2K | — | |
DYN | Kerr Douglas | — | Sep 4, 2025 | Proposed Sale | $13.27 | 4,552 | $60.4K | — | |
DYN | Kerr Douglas | — | Jun 5, 2025 | Proposed Sale | $13.35 | 1,342 | $17.9K | — | |
DYN | Kerr Douglas | — | Mar 5, 2025 | Proposed Sale | $11.89 | 1,343 | $16.0K | — |